TYR and melanoma: Due to the potent tyrosinase inhibitory activity, it is reasoned that HNB suppressed cellular tyrosinase activity and total melanin content to 27% and 35%, respectively, in melanoma cells at 100 μM concentration, where cells maintained 87% viability [79].